We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Multiplex Testing Speeds Up CNS Infection Diagnosis

By LabMedica International staff writers
Posted on 16 Aug 2018
Print article
Image: The FilmArray System is the new standard for syndromic infectious disease diagnostics (Photo courtesy of BioFire Diagnostics).
Image: The FilmArray System is the new standard for syndromic infectious disease diagnostics (Photo courtesy of BioFire Diagnostics).
A variety of viral, bacterial, and fungal pathogens cause infections of the central nervous system (CNS), which range in severity from mild and self-limiting to severe and life-threatening. Initial symptoms like headache, fever, photophobia, and neck stiffness are not organism-specific so cannot be used to guide therapy.

Current microbiologic methods identify a specific organism in only 30%-50% of patients with presumed CNS infections, largely due to poor culture sensitivity stemming from the low concentration of organism in cerebrospinal fluid (CSF) and low volume of CSF collected for microbiologic analysis.

An assistant professor of pathology at the Medical College of Wisconsin (Milwaukee, WI, USA) has suggested that a multiplex testing approach simplifies ordering for clinicians and provides a relatively comprehensive result in as little as 60 minutes. Using multiplexed tests to analyze CSF resulted in a 44% to 600% increase in specimens with an identified organism, mostly due to nucleic acid amplification tests (NAATs’) increased sensitivity compared to culture.

While potentially beneficial, the significance of detecting these additional organisms needs to be considered in the context of other laboratory values and a patient’s clinical status. The FilmArray ME panel identified Streptococcus pneumoniae in an additional 12 CSF specimens when compared to culture; however, seven of these patients had no clinical or laboratory evidence of S. pneumoniae suggesting a false positive result potentially due to external contamination of the specimens.

Consequently, despite having a specificity of more than 99% for S. pneumoniae the test’s positive predictive value was just 60%. Similarly, a definitive diagnosis of CNS infection was made in only 11% of human herpesvirus-6 and 33% of CMV-positive specimens, possibly due to latent virus present within leukocytes in CSF rather than an indication of active disease. Combined, these data underscore the need to correlate FA-ME results with other laboratory values and host factors to validate a result, especially in cases with results unexpected or inconsistent with a patient’s risk factors and clinical course.

The FA-ME test identifies 14 microorganisms frequently associated with community acquired CNS infections. However, other patient populations including those with traumatic injury or surgery involving the CNS are susceptible to pathogens that are not part of the FA-ME panel. In these patients, FA-ME lacks broad utility, and a negative FA-ME result could be misleading. Blake W. Buchan, PhD, D(ABMM), the author of the study concluded that for these reasons, laboratories need to develop criteria to optimize the benefit from FA-ME testing including selecting appropriate patient populations and rejecting specimens. The study was published on August 1, 2018, in the journal Clinical Laboratory News.

Related Links:
Medical College of Wisconsin

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.